2 United States Patent
Gupte et al.
‘US010081597B2
US 10,081,597 B2
Sep. 25, 2018
(a0) Patent No.
4s) Date of Patent:
(54) PROCESS FOR PREPARATION OF
DEXMETHYLPHENDATE,
HYDROCHLORIDE
(71) Applicant: Embio Limited, Mumbai (IN)
(72) Inventors: Ashutosh Digambar Gupte, Mumbi
(IN); Sunil Vaman Joshi, Mumbsi
(IN); Amit Hari Pakhurde, Mumbai
aN)
oe
Assignee: Emblo Limited, Mumbai (IN)
(*) Notice: Subject to aay disclaimer the term ofthis
patent is extended or adjusted under 35
USC. 154(b) by 0 days
ey
Appl. Nos 15)
20511
(22) PCT Filed: Nov. 3, 2014
(86) PCT No.
$371 @XD,
(2) Date
PCTB20149065763
Dec. 20, 2016
(87) PCT Pub, No: Wo201s/198108
PCY Pub, Date: Dee. 30, 2015
) Prior Publication Data
US 201710217886 Al Avg. 3, 2017
G0) Foreign Application Prlority Data
Jun, 27, 2014 (IN) 2090/MUMI2014
(51) Intl
cov 21034
(2) US.CL
PC
(2006.01)
CO7D 211/34 (2013.01); C7B 220007
(2013.01)
(58) Fleld of Classification Seareh
Pc COTD 21134; CO7B 2200/07
uspc 546/238
See application file for complete search history.
66) References Cited
US. PATENT DOCUMENTS
6.100401 4 * $2000 Prashad cov 204
546.253
6162919 4122000 Prashad
91063100 B2 62015 Nason
9.204460 2122015 Opiate
20080277791 AL 122005 Nishiyama etal
FOREIGN PATENT DOCUMENTS
wo swm2s902 6 1998
(OTHER PUBLICATIONS,
Alivich Catalogue 1998-1999, p 10, p. 699, 3 pages *
* cited by examiner
Primary Examiner — Taylor V Oh
(74) Auornes, Agent, or Firm —Blueshift IP, LLC
Robert Plotkin
on
The present invention relates toa process for preparation of
dexmethylpheaidate hydrochloride from racemic methyl
phenidate. The process involves the treatment of racemic
nixture of d-threo-methy|phenidate base in the presence of
ipivaloy!-D-tararie acid (D-DPTA) in a solvent to isolate
ipivaloyl tartrate salt of d-threo-methyphenidate. The
ipivaloyltanrate salt of d-threo-methyiphenidat is treated
witha base to obtain a d-threo-methylphenidate base, which
is extracted using a suitable solvent, The ¢-threo-methy
phenidate base is treated with hydrochloric aci-isopropy!
‘aleohol solution to obtain slur of d-threo-methylphenidate
hydrochloride also known as’ dexmethylphenidate hydro
chloride. The dexmethylphenidate hydrochloride slurry is
filtered and washed with acetone, The invention also dis
closes a process for recovery of D-DPTA from the salt
‘mother liquor and from the spent aqueous layer. The process
{is economical, environmental iendly and results in
increased yield and optically pure dexmethylphenidate
hydrochloride,
ABSTRACT
10 Claims, No Drawings‘US 10,081,597 B2
1
PROCESS FOR PREPARATION OF
DEXMETHYLPHENIDATE
HYDROCHLORIDE
‘TECHNICAL FIELD OF THE INVENTION
‘The present invention relates to a process for preparation
of dexmethylphenidate hydrochloride from racemic meth-
ylphenidate. The process involves the preparation of tartaric
salts of methylphenidate and conversion of tartaric salts of
methylphenidate to enantiomers of methylphenidate hydro-
chloride,
BACKGROUND OF THE INVENTION
Methylphenidate hydrochloride is « psychostimulant of
phenethylamine class. The dmug is safe, effective and
‘approved forthe treatment of atention-dficit hyperactivity
disorder (ADHD), postural orthostatic tachycardia. syn-
‘drome and narcolepsy in human, Long-term teatment with,
methyiphenidate hydrochloride ineeases the activity of en
teal nervous system, reduces the structural and functional
slbnommalites in the brain,
Dexmethylphenidate, also known a8 d-threo-methyl-
phenidate(D-TMP) isa dextortstory enantiomer of meth- 2
Yinhenidat, which is also effective psychostimulant against
ADHD. Dexmethyiphenidate is the (RR) enantiomer of
inetyiphenidae
‘Racemic methylphenidate contains both dexto- and Levo-
rotatory methyphenidate which ae wsefl forthe treatment
‘ofADHD. Iis very challenging to isolate a puritid form of